siRNA treatment reduces triglycerides in individuals with uncommon health condition
.ANALYSIS EMPHASIZE.19 September 2024.
Plozasiran decreased triglyceride amounts by 80% as well as lowered the risk of pancreatitis in individuals along with persistent chylomicronemia, with or without a genetic prognosis.